Effects of Ramipril on Endothelial Function and the Expression of Proinflammatory Cytokines and Adhesion Molecules in Young Normotensive Subjects With Successfully Repaired Coarctation of Aorta. A Randomized Cross-Over Study

Journal of the American College of Cardiology

Volumn 51, Issue 7, 2008, Pages 742-749

  Brili, Stella ^a   Tousoulis, Dimitris ^a   Antoniades, Charalambos ^a   Vasiliadou, Carmen ^a   Karali, Maria ^a   Papageorgiou, Nikos ^a   Ioakeimidis, Nikos ^a   Marinou, Kyriakoula ^a   Stefanadi, Elli ^a   Stefanadis, Christodoulos ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CD40 LIGAND; INTERLEUKIN 1BETA; INTERLEUKIN 6; RAMIPRIL; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; ANTIHYPERTENSIVE ACTIVITY; AORTA COARCTATION; ARTICLE; BLOOD PRESSURE REGULATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; CYTOKINE PRODUCTION; DRUG EFFECT; ENDOTHELIAL DYSFUNCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOREARM; FUNCTIONAL ASSESSMENT; HUMAN; INFLAMMATION; MALE; PLETHYSMOGRAPHY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL; VASCULAR ENDOTHELIUM;

ADULT; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; AORTIC COARCTATION; C-REACTIVE PROTEIN; CD40 LIGAND; CROSS-OVER STUDIES; ENDOTHELIUM, VASCULAR; FEMALE; FOREARM; HUMANS; INTERLEUKIN-1BETA; MALE; PLETHYSMOGRAPHY; RAMIPRIL; REGIONAL BLOOD FLOW; VASCULAR CELL ADHESION MOLECULE-1;

EID: 38949118304     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2007.10.036     Document Type: Article

References (37)

1. Cohen M., Fuster V., Steele P.M., Driscoll D., and McGoon D.C. Coarctation of the aorta. Long-term follow-up and prediction of outcome after surgical correction. Circulation 80 (1989) 840-845
2. Meyer A.A., Joharchi M.S., Kundt G., Schuff-Werner P., Steinhoff G., and Kienast W. Predicting the risk of early atherosclerotic disease development in children after repair of aortic coarctation. Eur Heart J 26 (2005) 617-622
3. de Divitiis M., Pilla C., Kattenhorn M., et al. Vascular dysfunction after repair of coarctation of the aorta: impact of early surgery. Circulation 104 (2001) I165-I170
4. Brili S., Tousoulis D., Antoniades C., et al. Evidence of vascular dysfunction in young patients with successfully repaired coarctation of aorta. Atherosclerosis 182 (2005) 97-103
5. Brili S., Dernellis J., Aggeli C., et al. Aortic elastic properties in patients with repaired coarctation of aorta. Am J Cardiol 82 (1998) 1140-1143
6. Gardiner H.M., Celermajer D.S., Sorensen K.E., et al. Arterial reactivity is significantly impaired in normotensive young adults after successful repair of aortic coarctation in childhood. Circulation 89 (1994) 1745-1750
7. Sehested J., Baandrup U., and Mikkelsen E. Different reactivity and structure of the prestenotic and poststenotic aorta in human coarctation. Implications for baroreceptor function. Circulation 65 (1982) 1060-1065
8. Celermajer D.S., and Greaves K. Survivors of coarctation repair: fixed but not cured. Heart 88 (2002) 113-114
9. Dagenais G.R., Pogue J., Fox K., Simoons M.L., and Yusuf S. Angiotensin-converting-enzyme inhibitors in stable vascular disease without left ventricular systolic dysfunction or heart failure: a combined analysis of three trials. Lancet 368 (2006) 581-588
10. Watanabe T., Barker T.A., and Berk B.C. Angiotensin II and the endothelium: diverse signals and effects. Hypertension 45 (2005) 163-169
11. Paridon S.M., Alpert B.S., Boas S.R., et al. Clinical stress testing in the pediatric age group: a statement from the American Heart Association Council on Cardiovascular Disease in the Young, Committee on Atherosclerosis, Hypertension, and Obesity in Youth. Circulation 113 (2006) 1905-1920
12. Tousoulis D., Antoniades C., and Stefanadis C. Evaluating endothelial function in humans: a guide to invasive and noninvasive techniques. Heart 91 (2005) 553-558
13. Ong C.M., Canter C.E., Gutierrez F.R., Sekarski D.R., and Goldring D.R. Increased stiffness and persistent narrowing of the aorta after successful repair of coarctation of the aorta: relationship to left ventricular mass and blood pressure at rest and with exercise. Am Heart J 123 (1992) 1594-1600
14. De Caro E., Trocchio G., Smeraldi A., Calevo M.G., and Pongiglione G. Aortic arch geometry and exercise-induced hypertension in aortic coarctation. Am J Cardiol 99 (2007) 1284-1287
15. Gidding S.S., Rocchini A.P., Moorehead C., Schork M.A., and Rosenthal A. Increased forearm vascular reactivity in patients with hypertension after repair of coarctation. Circulation 71 (1985) 495-499
16. Modena M.G., Bonetti L., Coppi F., Bursi F., and Rossi R. Prognostic role of reversible endothelial dysfunction in hypertensive postmenopausal women. J Am Coll Cardiol 40 (2002) 505-510
17. Ou P., Bonnet D., Auriacombe L., et al. Late systemic hypertension and aortic arch geometry after successful repair of coarctation of the aorta. Eur Heart J 25 (2004) 1853-1859
18. Parker Jr. F.B., Streeten D.H., Farrell B., Blackman M.S., Sondheimer H.M., and Anderson Jr. G.H. Preoperative and postoperative renin levels in coarctation of the aorta. Circulation 66 (1982) 513-514
19. de Divitiis M., Rubba P., and Calabro R. Arterial hypertension and cardiovascular prognosis after successful repair of aortic coarctation: a clinical model for the study of vascular function. Nutr Metab Cardiovasc Dis 15 (2005) 382-394
20. Weir M.R., and Dzau V.J. The renin-angiotensin-aldosterone system: a specific target for hypertension management. Am J Hypertens 12 (1999) 205S-213S
21. Xu J., Shiota T., Omoto R., et al. Intravascular ultrasound assessment of regional aortic wall stiffness, distensibility, and compliance in patients with coarctation of the aorta. Am Heart J 134 (1997) 93-98
22. Ghaleh B., Hittinger L., Kim S.J., et al. Selective large coronary endothelial dysfunction in conscious dogs with chronic coronary pressure overload. Am J Physiol 274 (1998) H539-H551
23. Bezerra S.M., dos Santos C.M., Moreira E.D., Krieger E.M., and Michelini L.C. Chronic AT (1) receptor blockade alters autonomic balance and sympathetic responses in hypertension. Hypertension 38 (2001) 569-575
24. Gidding S.S., Rocchini A.P., Beekman R., et al. Therapeutic effect of propranolol on paradoxical hypertension after repair of coarctation of the aorta. N Engl J Med 312 (1985) 1224-1228
25. Leenen F.H., Balfe J.A., Pelech A.N., Barker G.A., Balfe J.W., and Olley P.M. Postoperative hypertension after repair of coarctation of aorta in children: protective effect of propranolol?. Am Heart J 113 (1987) 1164-1173
26. Brasier A.R., Recinos III A., and Eledrisi M.S. Vascular inflammation and the renin-angiotensin system. Arterioscler Thromb Vasc Biol 22 (2002) 1257-1266
27. Tousoulis D., Antoniades C., Koumallos N., and Stefanadis C. Pro-inflammatory cytokines in acute coronary syndromes: from bench to bedside. Cytokine Growth Factor Rev 17 (2006) 225-233
28. Sesso H.D., Buring J.E., Rifai N., Blake G.J., Gaziano J.M., and Ridker P.M. C-reactive protein and the risk of developing hypertension. JAMA 290 (2003) 2945-2951
29. Rodriguez-Iturbe B., Quiroz Y., Kim C.H., and Vaziri N.D. Hypertension induced by aortic coarctation above the renal arteries is associated with immune cell infiltration of the kidneys. Am J Hypertens 18 (2005) 1449-1456
30. Navalkar S., Parthasarathy S., Santanam N., and Khan B.V. Irbesartan, an angiotensin type 1 receptor inhibitor, regulates markers of inflammation in patients with premature atherosclerosis. J Am Coll Cardiol 37 (2001) 440-444
31. Faggiotto A., and Paoletti R. State-of-the-art lecture. Statins and blockers of the renin-angiotensin system: vascular protection beyond their primary mode of action. Hypertension 34 (1999) 987-996
32. Zarich S.W. Treating the diabetic patient: appropriate care for glycemic control and cardiovascular disease risk factors. Rev Cardiovasc Med 4 Suppl 6 (2003) S19-S28
33. Hunyady L., and Catt K.J. Pleiotropic AT1 receptor signaling pathways mediating physiological and pathogenic actions of angiotensin II. Mol Endocrinol 20 (2006) 953-970
34. Ferrario C.M., and Strawn W.B. Role of the renin-angiotensin-aldosterone system and proinflammatory mediators in cardiovascular disease. Am J Cardiol 98 (2006) 121-128
35. Ballantyne C.M., and Nambi V. Markers of inflammation and their clinical significance. Atheroscler Suppl 6 (2005) 21-29
36. Schonbeck U., Varo N., Libby P., Buring J., and Ridker P.M. Soluble CD40L and cardiovascular risk in women. Circulation 104 (2001) 2266-2268
37. Tousoulis D., Antoniades C., and Stefanadis C. Assessing inflammatory status in cardiovascular disease. Heart 93 (2007) 1001-1007